Kurt E - Search Results

1

A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.

Kurt E, Cubukcu E, Karabulut B, Olmez OF, Kurt M, Avci N, Ozdemir F, Tunali D, Evrensel T, Manavoglu O. Kurt E, et al. Among authors: kurt m. J BUON. 2013 Jan-Mar;18(1):147-53. J BUON. 2013. PMID: 23613400 Free article.

2

Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer.

Kurt E, Kurt M, Kanat O, Cetintas SK, Aygun S, Palazoglu T, Ozkan L, Evrensel T, Kaya E, Manavoglu O. Kurt E, et al. Among authors: kurt m. Tumori. 2006 Nov-Dec;92(6):481-6. doi: 10.1177/030089160609200603. Tumori. 2006. PMID: 17260487 Clinical Trial.

3

Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer.

Bayrak M, Olmez OF, Kurt E, Cubukcu E, Evrensel T, Kanat O, Manavoglu O. Bayrak M, et al. Among authors: kurt e. Clin Transl Oncol. 2013 Apr;15(4):307-12. doi: 10.1007/s12094-012-0921-0. Epub 2012 Aug 22. Clin Transl Oncol. 2013. PMID: 22911549

4

Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M, Kurt E, Evrensel T. Avci N, et al. Among authors: kurt e. J BUON. 2015 Jan-Feb;20(1):45-9. J BUON. 2015. PMID: 25778295 Free article.

5

Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy.

Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Altmisdortoglu O, Tanriverdi O, Aksoy A, Kurt E, Evrensel T. Avci N, et al. Among authors: kurt e. J BUON. 2015 Jul-Aug;20(4):994-1000. J BUON. 2015. PMID: 26416041

6

Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer.

Deligonul A, Evrensel T, Avci N, Ugras N, Ture M, Cubukcu E, Hartavi M, Fatih Olmez O, Kurt E, Tolunay S, Kanat O, Manavoglu O. Deligonul A, et al. Among authors: kurt e. J BUON. 2016 May-Jun;21(3):564-9. J BUON. 2016. PMID: 27569073 Free article.

7

Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors.

Cubukcu E, Olmez OF, Avci N, Canhoroz M, Kurt E, Kanat O, Evrensel T, Manavoglu O. Cubukcu E, et al. Among authors: kurt e. J BUON. 2012 Jul-Sep;17(3):517-21. J BUON. 2012. PMID: 23033292

8

Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.

Cubukcu E, Kanat O, Fatih Olmez O, Kabul S, Canhoroz M, Avci N, Deligonul A, Hartavi M, Cubukcu S, Olmez F, Kurt E, Evrensel T, Gokgoz S, Manavoglu O. Cubukcu E, et al. Among authors: kurt e. J BUON. 2013 Apr-Jun;18(2):359-65. J BUON. 2013. PMID: 23818346 Free article.

9

Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer: a single center randomized study.

Kanat O, Evrensel T, Baran I, Coskun H, Zarifoglu M, Turan OF, Kurt E, Demiray M, Gonullu G, Manavoglu O. Kanat O, et al. Among authors: kurt e. Med Oncol. 2003;20(3):237-45. doi: 10.1385/MO:20:3:237. Med Oncol. 2003. PMID: 14514973 Clinical Trial.

10

Single-agent irinotecan as second-line treatment for advanced gastric cancer.

Kanat O, Evrensel T, Manavoglu O, Demiray M, Kurt E, Gonullu G, Kiyici M, Arslan M. Kanat O, et al. Among authors: kurt e. Tumori. 2003 Jul-Aug;89(4):405-7. doi: 10.1177/030089160308900411. Tumori. 2003. PMID: 14606644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters